account_num,net_change,tag,tag_depth,cik
759,99497.0,InventoryWriteDown,1,"793171_VITRO BIOPHARMA, INC."
501,251720.0,Cash,1,"793171_VITRO BIOPHARMA, INC."
69,251720.0,CashAndDueFromBanks,2,"793171_VITRO BIOPHARMA, INC."
2614,793175.0,PreferredStockDividendsIncomeStatementImpact,2,"793171_VITRO BIOPHARMA, INC."
2744,793175.0,PreferredStockDividendsAndOtherAdjustments,2,"793171_VITRO BIOPHARMA, INC."
795,99497.0,ProductionRelatedImpairmentsOrCharges,1,"793171_VITRO BIOPHARMA, INC."
894,914091.0,GoodwillImpairmentLoss,2,"793171_VITRO BIOPHARMA, INC."
825,914091.0,GoodwillAndIntangibleAssetImpairment,2,"793171_VITRO BIOPHARMA, INC."
525,6279.0,AccretionExpenseIncludingAssetRetirementObligations,2,"793171_VITRO BIOPHARMA, INC."
3334,-200000.0,LongTermNotesAndLoans,3,"793171_VITRO BIOPHARMA, INC."
3342,-200000.0,LongTermNotesPayable,2,"793171_VITRO BIOPHARMA, INC."
560,1667438.0,DeferredCostsCurrent,2,"793171_VITRO BIOPHARMA, INC."
722,6279.0,AccretionExpense,1,"793171_VITRO BIOPHARMA, INC."
3225,-200000.0,ConvertibleLongTermNotesPayable,2,"793171_VITRO BIOPHARMA, INC."
1170,1667438.0,DeferredOfferingCosts,1,"793171_VITRO BIOPHARMA, INC."
3535,-136.0,PreferredStockValue,3,"793171_VITRO BIOPHARMA, INC."
2903,-2604825.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,"793171_VITRO BIOPHARMA, INC."
3618,-641080.0,DerivativeInstrumentsAndHedgesLiabilitiesNoncurrent,4,"793171_VITRO BIOPHARMA, INC."
802,914091.0,AssetImpairmentCharges,1,"793171_VITRO BIOPHARMA, INC."
1820,-2520803.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,"793171_VITRO BIOPHARMA, INC."
1077,-2520803.0,ProfitLoss,2,"793171_VITRO BIOPHARMA, INC."
1912,-2604825.0,NetIncomeLoss,1,"793171_VITRO BIOPHARMA, INC."
2590,-2604825.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,"793171_VITRO BIOPHARMA, INC."
2552,-958774.0,AccruedLiabilitiesCurrent,2,"793171_VITRO BIOPHARMA, INC."
3817,84000.0,TreasuryStockValue,2,"793171_VITRO BIOPHARMA, INC."
162,99497.0,CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization,6,"793171_VITRO BIOPHARMA, INC."
171,129145.0,CostOfGoodsAndServicesSold,2,"793171_VITRO BIOPHARMA, INC."
144,129145.0,CostOfRevenue,1,"793171_VITRO BIOPHARMA, INC."
491,73280.0,ResearchAndDevelopmentExpense,2,"793171_VITRO BIOPHARMA, INC."
581,993650.0,OperatingCostsAndExpenses,2,"793171_VITRO BIOPHARMA, INC."
1133,914091.0,RestructuringSettlementAndImpairmentProvisions,3,"793171_VITRO BIOPHARMA, INC."
2710,-839970.0,DeferredRevenueCurrent,2,"793171_VITRO BIOPHARMA, INC."
3347,-641080.0,DerivativeLiabilitiesNoncurrent,2,"793171_VITRO BIOPHARMA, INC."
2257,-2520803.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,"793171_VITRO BIOPHARMA, INC."
455,224475.0,InventoryNet,2,"793171_VITRO BIOPHARMA, INC."
260,224475.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,"793171_VITRO BIOPHARMA, INC."
677,122149.0,PrepaidExpenseCurrent,2,"793171_VITRO BIOPHARMA, INC."
868,2643626.0,AssetsCurrent,2,"793171_VITRO BIOPHARMA, INC."
1634,251694.0,OperatingLeaseRightOfUseAsset,2,"793171_VITRO BIOPHARMA, INC."
1368,288171.0,PropertyPlantAndEquipmentNet,4,"793171_VITRO BIOPHARMA, INC."
1711,3608949.0,Goodwill,1,"793171_VITRO BIOPHARMA, INC."
320,47539.0,ReceivablesNetCurrent,3,"793171_VITRO BIOPHARMA, INC."
1732,1311533.0,IntangibleAssetsNetExcludingGoodwill,2,"793171_VITRO BIOPHARMA, INC."
2041,13860.0,OtherAssetsNoncurrent,2,"793171_VITRO BIOPHARMA, INC."
2091,5474207.0,AssetsNoncurrent,2,"793171_VITRO BIOPHARMA, INC."
2089,8156116.0,Assets,1,"793171_VITRO BIOPHARMA, INC."
2398,-917259.0,AccountsPayableCurrent,2,"793171_VITRO BIOPHARMA, INC."
2347,-1876033.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,"793171_VITRO BIOPHARMA, INC."
2809,-65461.0,FinanceLeaseLiabilityCurrent,3,"793171_VITRO BIOPHARMA, INC."
1827,4920482.0,IntangibleAssetsNetIncludingGoodwill,2,"793171_VITRO BIOPHARMA, INC."
2737,-65461.0,LongTermDebtAndCapitalLeaseObligationsCurrent,3,"793171_VITRO BIOPHARMA, INC."
207,47539.0,AccountsNotesAndLoansReceivableNetCurrent,4,"793171_VITRO BIOPHARMA, INC."
577,741538.0,CashCashEquivalentsAndShortTermInvestments,4,"793171_VITRO BIOPHARMA, INC."
229,47539.0,AccountsReceivableNetCurrent,3,"793171_VITRO BIOPHARMA, INC."
645,741538.0,CashAndCashEquivalentsAtCarryingValue,3,"793171_VITRO BIOPHARMA, INC."
2638,-65461.0,DebtCurrent,2,"793171_VITRO BIOPHARMA, INC."
3308,-200000.0,LongTermDebtNoncurrent,2,"793171_VITRO BIOPHARMA, INC."
2149,-2520803.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,"793171_VITRO BIOPHARMA, INC."
1854,11901.0,InterestAndDebtExpense,2,"793171_VITRO BIOPHARMA, INC."
3154,-2851451.0,LiabilitiesCurrent,2,"793171_VITRO BIOPHARMA, INC."
1709,11901.0,InterestExpense,1,"793171_VITRO BIOPHARMA, INC."
1112,3962441.0,OperatingExpenses,1,"793171_VITRO BIOPHARMA, INC."
3378,-45592.0,FinanceLeaseLiabilityNoncurrent,3,"793171_VITRO BIOPHARMA, INC."
3303,-245592.0,LongTermDebtAndCapitalLeaseObligations,2,"793171_VITRO BIOPHARMA, INC."
3379,-204207.0,OperatingLeaseLiabilityNoncurrent,3,"793171_VITRO BIOPHARMA, INC."
3796,-845287.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,"793171_VITRO BIOPHARMA, INC."
3645,-4419625.0,LiabilitiesNoncurrent,2,"793171_VITRO BIOPHARMA, INC."
3465,-7271076.0,Liabilities,1,"793171_VITRO BIOPHARMA, INC."
3661,-115440.0,CommonStockValue,3,"793171_VITRO BIOPHARMA, INC."
1264,-2508902.0,OperatingIncomeLoss,1,"793171_VITRO BIOPHARMA, INC."
3750,-26177841.0,AdditionalPaidInCapital,1,"793171_VITRO BIOPHARMA, INC."
3316,-885040.0,StockholdersEquity,1,"793171_VITRO BIOPHARMA, INC."
3260,-885040.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,"793171_VITRO BIOPHARMA, INC."
3917,-8156116.0,LiabilitiesAndStockholdersEquity,2,"793171_VITRO BIOPHARMA, INC."
173,-651874.0,Revenues,1,"793171_VITRO BIOPHARMA, INC."
232,-522729.0,GrossProfit,1,"793171_VITRO BIOPHARMA, INC."
601,2958351.0,SellingGeneralAndAdministrativeExpense,3,"793171_VITRO BIOPHARMA, INC."
692,10440.0,ProvisionForDoubtfulAccounts,2,"793171_VITRO BIOPHARMA, INC."
3834,-25324241.0,RetainedEarningsAccumulatedDeficit,1,"793171_VITRO BIOPHARMA, INC."
